Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries
S. Hamasaki et al., Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries, ART THROM V, 20(3), 2000, pp. 737-743
Coronary vascular remodeling and altered endothelial function have been des
cribed in the early stages of native atherosclerosis. The purpose of this s
tudy was to evaluate the association between cholesterol-lowering therapy a
nd coronary vascular remodeling and endothelial function in patients with n
ormal or mildly diseases coronary arteries. Patients (N=101) with normal or
mildly diseased coronary arteries by coronary angiography underwent intrav
ascular ultrasound examination of the left anterior descending coronary art
ery. Vessel and lumen area, atherosclerotic plaque area, and plaque morphol
ogy were evaluated. Vascular reactivity was examined with the use of intrac
oronary adenosine, acetylcholine, and nitroglycerin. Patients were divided
into 3 groups based on the total cholesterol levels: group 1 (n=25), patien
ts with a history of hypercholesterolemia adequately treated (total cholest
erol <240 mg/dL); group 2 (n=26), patients with hypercholesterolemia not ad
equately controlled (total cholesterol greater than or equal to 240 mg/dL);
and group 3 (n=50), patients without hypercholesterolemia. Vessel area and
lumen area were significantly greater in groups 1 and 3 than in group 2 (f
or respective values in groups 1, 2, and 3: vessel area 11.9+/-0.5, 10.6+/-
0.4, and 11.8+/-0.4 mm(2), both P<0.05; lumen area 8.3+/-0.4, 6.9+/-0.3. an
d 8.9+/-0.3 mm(2), both P<0.01). However, plaque areas in groups 1 and 2 we
re similar. Furthermore, acetylcholine-induced percent increases in coronar
y blood flow were significantly greater in groups 1 and 3 than in group 2 (
for respective values in groups 1, 2, and 3: 70.5+/-20.1%, 22.8+/-13.7%, an
d 68.6+/-14.8%, both P<0.05). Cholesterol-lowering treatment is associated
with an improvement in coronary lumen area that results not from a decrease
in plaque area but from an increase in vessel area, reflecting vascular re
modeling. Additionally, this adaptive process may occur in association with
an improvement of endothelium-dependent vasodilation of the resistance cor
onary artery.